203 related articles for article (PubMed ID: 9269055)
1. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
Keitel WA; Cate TR; Couch RB; Huggins LL; Hess KR
Vaccine; 1997 Jul; 15(10):1114-22. PubMed ID: 9269055
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
Keitel WA; Cate TR; Couch RB
Am J Epidemiol; 1988 Feb; 127(2):353-64. PubMed ID: 3337087
[TBL] [Abstract][Full Text] [Related]
3. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
Keitel WA
Semin Pediatr Infect Dis; 2002 Apr; 13(2):112-9. PubMed ID: 12122949
[TBL] [Abstract][Full Text] [Related]
4. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
6. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
Nunzi E; Iorio AM; Camilloni B
Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of influenza vaccine Vaxigrip in the combined immunization of conscripts during influenza seasons of 2002-2003].
Burtseva EI; Vlasova LN; Shevchenko ES; Sabanin IuV; Rikhter VV; Artiukov RM; Rybin VV; Tarasevich NN; Slepushkin AN
Zh Mikrobiol Epidemiol Immunobiol; 2004; (1):49-55. PubMed ID: 15024982
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
Arnoux S; Weinberger C; Gessner BD
Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
[TBL] [Abstract][Full Text] [Related]
11. [Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection].
Slobodniuk AV; Romanenko VV; Utnitskaia OS; Motus TM; Pereverzev AV
Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):36-9. PubMed ID: 12449696
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults.
Frey S; Vesikari T; Szymczakiewicz-Multanowska A; Lattanzi M; Izu A; Groth N; Holmes S
Clin Infect Dis; 2010 Nov; 51(9):997-1004. PubMed ID: 20868284
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
[TBL] [Abstract][Full Text] [Related]
14. Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88.
Slepushkin AN; Obrosova-Serova NP; Burtseva EI; Rudenko LG; Govorkova EA; Vartanyan RV; Verestsinsky AI; Lonskaya NI; Harmon MW; Torok T
Vaccine; 1993; 11(3):323-8. PubMed ID: 8447161
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
18. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.
Palache AM; Beyer WE; Lüchters G; Völker R; Sprenger MJ; Masurel N
Vaccine; 1993; 11(9):892-908. PubMed ID: 8212834
[TBL] [Abstract][Full Text] [Related]
20. [Influenza vaccination. Effectiveness of current vaccines and future challenges].
Ortiz de Lejarazu R; Tamames S
Enferm Infecc Microbiol Clin; 2015; 33(7):480-90. PubMed ID: 26232121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
